CAMILLE WASHOWICH: Open Payments
NPI 1467422071 · SANTA CRUZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 21 payments from 7 companies in 2025. Trend: 2023 $168 · 2024 $313 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $140 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $16 |
Products named: TRELEGY ELLIPTA, Tlando, JARDIANCE, Rybelsus, PREVNAR 20, REXULTI, LOREEV XR.
Industry payments across CA — which companies pay providers there.
